← Open Payments lookup

AMELIA FASCIANO: Open Payments

NPI 1083189054 · PARAMUS, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$736 in 11 payments from 8 companies in 2025. Trend: 2023 $435 · 2024 $789 · 2025 $736

Food & beverage: $736
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP2$199
Otsuka America Pharmaceutical, Inc.2$127
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$108
Aimmune Therapeutics, Inc.1$103
Lilly USA, LLC1$72
Indivior Inc.1$71
Braeburn Inc.2$31
Alkermes, Inc.1$25

Products named: REXULTI, BREZTRI, CAPLYTA, ZENPEP, AIRSUPRA, MOUNJARO, SUBLOCADE, BRIXADI.

Industry payments across NJ — which companies pay providers there.